[{"address1": "9704 Medical Center Drive", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 251 5172", "fax": "301 251 5321", "website": "https://www.macrogenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Mr. James  Karrels", "age": 58, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 663431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric Blasius Risser", "age": 52, "title": "CEO, President & Director", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 651362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas M. Spitznagel Ph.D.", "age": 58, "title": "Senior Vice President of Technical Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 550974, "exercisedValue": 204497, "unexercisedValue": 490417}, {"maxAge": 1, "name": "Dr. Ezio  Bonvini M.D.", "age": 71, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 612208, "exercisedValue": 264031, "unexercisedValue": 199063}, {"maxAge": 1, "name": "Mr. Jeffrey Stuart Peters J.D.", "age": 54, "title": "Senior VP, General Counsel & Corporate Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Harig", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harish  Krishnaswamy", "title": "Senior Vice President of Business Development & Portfolio Planning", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank George Perabo FEBU, M.D., Ph.D.", "age": 61, "title": "Vice President & Interim Head of Clinical Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Smith", "age": 57, "title": "VP, Controller & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.79, "open": 1.81, "dayLow": 1.79, "dayHigh": 1.9, "regularMarketPreviousClose": 1.79, "regularMarketOpen": 1.81, "regularMarketDayLow": 1.79, "regularMarketDayHigh": 1.9, "payoutRatio": 0.0, "beta": 1.518, "forwardPE": -1.0660174, "volume": 1062797, "regularMarketVolume": 1062797, "averageVolume": 1329557, "averageVolume10days": 931200, "averageDailyVolume10Day": 931200, "bid": 1.17, "ask": 1.74, "bidSize": 2, "askSize": 2, "marketCap": 115763120, "fiftyTwoWeekLow": 0.99, "fiftyTwoWeekHigh": 3.365, "allTimeHigh": 41.0, "allTimeLow": 0.99, "priceToSalesTrailing12Months": 0.90704966, "fiftyDayAverage": 1.5163, "twoHundredDayAverage": 1.550575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6375113, "profitMargins": -0.59459996, "floatShares": 52619080, "sharesOutstanding": 63258532, "sharesShort": 3851323, "sharesShortPriorMonth": 3563452, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.060900003, "heldPercentInsiders": 0.03063, "heldPercentInstitutions": 0.58317, "shortRatio": 2.89, "shortPercentOfFloat": 0.0749, "impliedSharesOutstanding": 63258532, "bookValue": 1.059, "priceToBook": 1.7280453, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": -0.701, "netIncomeToCommon": -75886000, "trailingEps": -1.21, "forwardEps": -1.71667, "enterpriseToRevenue": 0.05, "enterpriseToEbitda": -0.06, "52WeekChange": -0.43533123, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 1.83, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.4, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 146396992, "totalCashPerShare": 2.314, "ebitda": -106061000, "totalDebt": 37009000, "quickRatio": 4.849, "currentRatio": 5.219, "totalRevenue": 127626000, "debtToEquity": 55.236, "revenuePerShare": 2.025, "returnOnAssets": -0.26525, "returnOnEquity": -0.81132007, "grossProfits": -55846000, "freeCashflow": -124597624, "operatingCashflow": -162468000, "earningsGrowth": -0.704, "revenueGrowth": -0.342, "grossMargins": -0.43758, "ebitdaMargins": -0.83102995, "operatingMargins": 0.25585, "financialCurrency": "USD", "symbol": "MGNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "MacroGenics, Inc.", "longName": "MacroGenics, Inc.", "corporateActions": [], "postMarketTime": 1767993004, "regularMarketTime": 1767992401, "exchange": "NMS", "messageBoardId": "finmb_600911", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.23464, "regularMarketPrice": 1.83, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1381411800000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.83, "postMarketChange": 0.0, "regularMarketChange": 0.0400001, "regularMarketDayRange": "1.79 - 1.9", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1329557, "fiftyTwoWeekLowChange": 0.84000003, "fiftyTwoWeekLowChangePercent": 0.8484849, "fiftyTwoWeekRange": "0.99 - 3.365", "fiftyTwoWeekHighChange": -1.535, "fiftyTwoWeekHighChangePercent": -0.45616642, "fiftyTwoWeekChangePercent": -43.533123, "earningsTimestamp": 1762981200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.21, "epsForward": -1.71667, "epsCurrentYear": -0.885, "priceEpsCurrentYear": -2.0677967, "fiftyDayAverageChange": 0.31370008, "fiftyDayAverageChangePercent": 0.20688523, "twoHundredDayAverageChange": 0.27942502, "twoHundredDayAverageChangePercent": 0.18020736, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "MacroGenics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]